Home » Healthcare » Pharmaceuticals » Carcinoembryonic Antigen (CEA) Market

Carcinoembryonic Antigen (CEA) Market, By Application (Ovarian Cancer, Colorectal Cancer, Pancreatic Cancer, Lung Cancer, Breast Cancer, Thyroid Cancer and Other Cancers) : Growth, Future Prospects, and Competitive Analysis, 2015 – 2027

Published: | Report ID: 2399 | Report Format : PDF

Market Insights

Carcinoembryonic antigen is a tumor marker, especially for cancers of the gastrointestinal tract. Carcinoembryonic antigens are glycoproteins that are frequently tested in the blood and play a major role in cell adhesion. The majority of colorectal, gastric, and pancreatic cancers, as well as some breast cancers, express carcinoembryonic antigens. Normal carcinoembryonic antigen levels in a healthy adult may increase due to benign disease or smoking. The carcinoembryonic antigen test measures the amount of carcinoembryonic antigen protein in the blood. Also, it is used to diagnose and manage particular types of cancers, for instance, cancer of the gastrointestinal tract, colon cancer, breast cancer, and others.

The carcinoembryonic antigen market is expected to reach a market value of USD 2,328.5 million in 2027, up from USD 1,753.7 million in 2020. It is expected to grow at a CAGR of over 4.1% during the forecast period.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

Key Market Drivers and Restraints     

The global rise in the number of cancer patients, especially colorectal cancer, is the key driving factor for the growth of the carcinoembryonic antigen market. There is an increasing demand for preclinical testing for the detection of illness, but carcinoembryonic antigen is the most cost-effective valuation, which continues to boost the demand for testing in the market. The rising disposable income of consumers, along with growing life expectancy, will eventually result in market growth. Furthermore, the presence of favorable government policies relating to cancer awareness and control by organizations such as the National Cancer Institute and the CPCRN is expected to positively emphasize market growth.

However, a less productive approach for cancer detection at the initial stage of treatment and less awareness about carcinoembryonic antigens are restraining the carcinoembryonic antigen market’s growth. Further, ineffective test results of the carcinoembryonic antigen test for hidden cancers at an early stage may hamper the market’s growth.

Impact of COVID-19

The COVID-19 pandemic has created a major disruption in the medical industry. Pharmaceutical companies and hospitals are working together with the government to reduce the infection of coronavirus. However, this sudden outbreak of COVID-19 has impacted the field of cancer care critically. This is attributed to the sudden imposition of social distancing, the delay in diagnoses and treatments, and the halting of clinical trials. While healthcare organizations are focusing on the timely treatment of cancer, considering it essential care, along with taking care to minimize coronavirus exposure,

How does the North American region dominate the global carcinoembryonic antigen market?

The global carcinoembryonic antigen market covers Asia Pacific, Europe, North America, the Middle East, Africa, and Latin America. North America dominates the market and accounts for the highest revenue share in the global market. This is attributed to the rising prevalence of cancer and the constantly improving healthcare infrastructure. Increasing patient awareness, along with the relatively higher healthcare expenditures of people in this region, boosts market growth. Growing key player investment in the research and development of technological innovation in the treatment of cancer is expected to continue the market’s dominance in North America.

The Asia Pacific region is expected to register a healthy revenue share in the carcinoembryonic antigen market, and one of the critical success factors spurring the growth of the market is promising government initiatives to control cancer diseases. Further, increasing patients’ awareness about the availability of cost-effective treatments for colorectal cancer is expected to boost demand in the forecast period.

Key application areas of the global carcinoembryonic antigen market are led by colorectal cancer.

The global carcinoembryonic antigen has a wide range of application areas, such as colorectal cancer, pancreatic cancer, ovarian cancer, breast cancer, thyroid cancer, and others. In 2020, the colorectal cancer segment will account for the highest market share of carcinoembryonic antigens. However, the breast cancer segment is expected to grow at a lucrative CAGR during the forecast period owing to the growing number of female populations in an emerging market.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

The global carcinoembryonic antigen market is dominated by hospitals owing to the rise in demand.

Rapid growth in the number of cancer patients and cancer incidences continue to rise in developed and developing countries, due to which cancer has become the leading cause of death in many parts of the world. According to the WHO, nearly 10 million deaths occur every year due to cancer, out of which 1.93 million were of the colon and rectum in the year 2020. Healthcare services are improving and focusing on diagnosing and treating diseases earlier. The primary factors driving the overall increase in incidence are population growth and lengthening life expectancy. Further, growing public awareness of cancer has increased the number of patients who undergo screening. Consumer awareness about the availability of early diagnosis methods makes processes more sophisticated, which in turn increases the market. This is attributed to the prevention of cancer by 30 to 50%.

1.Preface

1.1.Report Description
1.1.1.Purpose of the Report
1.1.2.Target Audience
1.1.3.USP and Key Offerings
1.2.Research Scope
1.3.Research Methodology
1.3.1.Phase I – Secondary Research
1.3.2.Phase II – Primary Research
1.3.3.Phase III – Expert Panel Review
1.3.4.Approach Adopted
1.3.4.1.Top-Down Approach
1.3.4.2.Bottom-Up Approach
1.3.5.Assumptions
1.4.Market Segmentation

2.Executive Summary

2.1.Market Snapshot: Global Carcinoembryonic Antigen Market

3.Market Dynamics

3.1.Introduction
3.1.1. Global Carcinoembryonic Antigen Market Value, 2015-2027, (US$ Mn)
3.2.Market Dynamics
3.2.1.Key Growth Trends
3.2.2.Major Industry Challenges
3.2.3.Key Growth Pockets
3.3.Attractive Investment Proposition,2020
3.3.1.Source
3.3.2.End-user
3.3.3.Geography

4.Market Positioning of Key Players, 2020

4.1.Company market share of key players, 2020
4.2.Top 6 Players
4.3.Top 3 Players
4.4.Major Strategies Adopted by Key Players

5.COVID 19 Impact Analysis

5.1.Global Carcinoembryonic Antigen Market Pre Vs Post COVID 19, 2019 – 2027
5.2.Impact on Import & Export
5.3.Impact on Demand & Supply

6.North America

6.1.North America Carcinoembryonic Antigen Market, by Country, 2015-2027(US$ Mn)
6.1.1.U.S.
6.1.2.Canada
6.1.3.Mexico
6.2.North America Carcinoembryonic Antigen Market, by Source, 2015-2027(US$ Mn)
6.2.1.Overview
6.2.2.Colorectal cancer
6.2.3.Pancreatic cancer
6.2.4.Ovarian cancer
6.2.5.Breast cancer
6.2.6.Thyroid cancer
6.2.7.Others
6.3.North America Carcinoembryonic Antigen Market, by End-user, 2015-2027(US$ Mn)
6.3.1.Overview
6.3.2.Hospitals
6.3.3.Laboratories
6.3.4.Others

7.Europe

7.1.Europe Carcinoembryonic Antigen Market, by Country, 2015-2027(US$ Mn)
7.1.1.UK
7.1.2.France
7.1.3.Germany
7.1.4.Italy
7.1.5.Russia
7.1.6.Spain
7.1.7.Belgium
7.1.8.Netherland
7.1.9.Austria
7.1.10.Sweden
7.1.11.Poland
7.1.12.Denmark
7.1.13.Switzerland
7.1.14.Rest of Europe
7.2.Europe Carcinoembryonic Antigen Market, by Source, 2015-2027(US$ Mn)
7.2.1.Overview
7.2.2.Colorectal cancer
7.2.3.Pancreatic cancer
7.2.4.Ovarian cancer
7.2.5.Breast cancer
7.2.6.Thyroid cancer
7.2.7.Others
7.3.Europe Carcinoembryonic Antigen Market, by End-user, 2015-2027(US$ Mn)
7.3.1.Overview
7.3.2.Hospitals
7.3.3.Laboratories
7.3.4.Others

8.Asia Pacific

8.1.Asia Pacific Carcinoembryonic Antigen Market, by Country, 2015-2027(US$ Mn)
8.1.1.China
8.1.2.Japan
8.1.3.South Korea
8.1.4.India
8.1.5.Australia
8.1.6.New Zealand
8.1.7.Taiwan
8.1.8.Southeast Asia
8.1.9.Central Asia
8.1.10.Rest of Asia Pacific
8.2.Asia Pacific Carcinoembryonic Antigen Market, by Source, 2015-2027(US$ Mn)
8.2.1.Overview
8.2.2.Colorectal cancer
8.2.3.Pancreatic cancer
8.2.4.Ovarian cancer
8.2.5.Breast cancer
8.2.6.Thyroid cancer
8.2.7.Others
8.3.Asia Pacific Carcinoembryonic Antigen Market, by End-user, 2015-2027(US$ Mn)
8.3.1.Overview
8.3.2.Hospitals
8.3.3.Laboratories
8.3.4.Others

9.Latin America

9.1.Latin America Carcinoembryonic Antigen Market, by Country, 2015-2027(US$ Mn)
9.1.1.Brazil
9.1.2.Argentina
9.1.3.Peru
9.1.4.Chile
9.1.5.Colombia
9.1.6.Rest of Latin America
9.2.Latin America Carcinoembryonic Antigen Market, by Source, 2015-2027(US$ Mn)
9.2.1.Overview
9.2.2.Colorectal cancer
9.2.3.Pancreatic cancer
9.2.4.Ovarian cancer
9.2.5.Breast cancer
9.2.6.Thyroid cancer
9.2.7.Others
9.3.Latin America Carcinoembryonic Antigen Market, by End-user, 2015-2027(US$ Mn)
9.3.1.Overview
9.3.2.Hospitals
9.3.3.Laboratories
9.3.4.Others

10.Middle East

10.1.Middle East Carcinoembryonic Antigen Market, by Country, 2015-2027(US$ Mn)
10.1.1.UAE
10.1.2.KSA
10.1.3.Israel
10.1.4.Turkey
10.1.5.Iran
10.1.6.Rest of Middle East
10.2.Middle East Carcinoembryonic Antigen Market, by Source, 2015-2027(US$ Mn)
10.2.1.Overview
10.2.2.Colorectal cancer
10.2.3.Pancreatic cancer
10.2.4.Ovarian cancer
10.2.5.Breast cancer
10.2.6.Thyroid cancer
10.2.7.Others
10.3.Middle East Carcinoembryonic Antigen Market, by End-user, 2015-2027(US$ Mn)
10.3.1.Overview
10.3.2.Hospitals
10.3.3.Laboratories
10.3.4.Others

11.Africa

11.1.Africa Carcinoembryonic Antigen Market, by Country, 2015-2027(US$ Mn)
11.1.1.South Africa
11.1.2.Egypt
11.1.3.Nigeria
11.1.4.Rest of Africa
11.2.Africa Carcinoembryonic Antigen Market, by Source, 2015-2027(US$ Mn)
11.2.1.Overview
11.2.2.Colorectal cancer
11.2.3.Pancreatic cancer
11.2.4.Ovarian cancer
11.2.5.Breast cancer
11.2.6.Thyroid cancer
11.2.7.Others
11.3.Africa Carcinoembryonic Antigen Market, by End-user, 2015-2027(US$ Mn)
11.3.1.Overview
11.3.2.Hospitals
11.3.3.Laboratories
11.3.4.Others

12.Global

12.1.Global Carcinoembryonic Antigen Market, by Source, 2015-2027(US$ Mn)
12.1.1.Overview
12.1.2.Colorectal cancer
12.1.3.Pancreatic cancer
12.1.4.Ovarian cancer
12.1.5.Breast cancer
12.1.6.Thyroid cancer
12.1.7.Others
12.2.Global Carcinoembryonic Antigen Market, by End-user, 2015-2027(US$ Mn)
12.2.1.Overview
12.2.2.Hospitals
12.2.3.Laboratories
12.2.4.Others

13.Company Profiles

13.1.F. Hoffmann-La Roche Ltd
13.2.Abbott Diagnostics
13.3.GenWay Biotech Inc.
13.4.Quest Diagnostics
13.5.Creative Diagnostics
13.6.Correlogic Systems, Inc.
13.7.Omega Diagnostics Group PLC
13.8.RayBiotech, Inc.
13.9.Boster Biological Technology
Qiagen N.V.

List of Figures

FIG. 1 Global Carcinoembryonic Antigen Market: Research Methodology

FIG. 2 Market Size Estimation – Top Down & Bottom up Approach

FIG. 3 Global Carcinoembryonic Antigen Market Segmentation

FIG. 4 Global Carcinoembryonic Antigen Market, by Product, 2019 (US$ Mn)

FIG. 5 Global Carcinoembryonic Antigen Market, by End-user, 2019 (US$ Mn)

FIG. 6 Global Carcinoembryonic Antigen Market, by Geography, 2019 (US$ Mn)

FIG. 7 Attractive Investment Proposition, by Geography, 2019

FIG. 8 Global Market Positioning of Key Carcinoembryonic Antigen Market Manufacturers, 2019

FIG. 9 Global Carcinoembryonic Antigen Market Value Contribution, By Source, 2019 & 2027 (Value %)

FIG. 10 Global Carcinoembryonic Antigen Market, by Colorectal Cancer, Value, 2015-2027 (US$ Mn)

FIG. 11 Global Carcinoembryonic Antigen Market, by Pancreatic Cancer, Value, 2015-2027 (US$ Mn)

FIG. 12 Global Carcinoembryonic Antigen Market, by Ovarian Cancer, Value, 2015-2027 (US$ Mn)

FIG. 13 Global Carcinoembryonic Antigen Market, by Breast Cancer, Value, 2015-2027 (US$ Mn)

FIG. 14 Global Carcinoembryonic Antigen Market, by Thyroid Cancer, Value, 2015-2027 (US$ Mn)

FIG. 15 Global Carcinoembryonic Antigen Market, by Others, Value, 2015-2027 (US$ Mn)

FIG. 16 Global Carcinoembryonic Antigen Market Value Contribution, By End-User, 2019 & 2027 (Value %)

FIG. 17 Global Carcinoembryonic Antigen Market, by Hospitals, Value, 2015-2027 (US$ Mn)

FIG. 18 Global Carcinoembryonic Antigen Market, by Laboratories, Value, 2015-2027 (US$ Mn)

FIG. 19 Global Carcinoembryonic Antigen Market, by Others, Value, 2015-2027 (US$ Mn)

FIG. 20 U.S. Carcinoembryonic Antigen Market, 2015-2027 (US$ Mn)

FIG. 21 Rest of North America Carcinoembryonic Antigen Market, 2015-2027 (US$ Mn)

FIG. 22 U.K. Carcinoembryonic Antigen Market, 2015-2027 (US$ Mn)

FIG. 23 Germany Carcinoembryonic Antigen Market, 2015-2027 (US$ Mn)

FIG. 24 France Carcinoembryonic Antigen Market, 2015-2027 (US$ Mn)

FIG. 25 Rest of Europe Carcinoembryonic Antigen Market, 2015-2027 (US$ Mn)

FIG. 26 Japan Carcinoembryonic Antigen Market, 2015-2027 (US$ Mn)

FIG. 27 China Carcinoembryonic Antigen Market, 2015-2027 (US$ Mn)

FIG. 28 India Carcinoembryonic Antigen Market, 2015-2027 (US$ Mn)

FIG. 29 Rest of Asia Pacific Carcinoembryonic Antigen Market, 2015-2027 (US$ Mn)

FIG. 30 Middle East & Africa Carcinoembryonic Antigen Market, 2015-2027 (US$ Mn)

Latin America Carcinoembryonic Antigen Market, 2015-2027 (US$ Mn)

List of Tables

TABLE 1 Market Snapshot: Global Carcinoembryonic Antigen Market

TABLE 2 Global Carcinoembryonic Antigen Market, by Source, 2015-2027 (US$ Mn)

TABLE 3 Global Carcinoembryonic Antigen Market, by End-user, 2015-2027 (US$ Mn)

TABLE 4 Global Carcinoembryonic Antigen Market, by Geography, 2015-2027 (US$ Mn)

TABLE 5 North America Carcinoembryonic Antigen Market, by Source, 2015-2027 (US$ Mn)

TABLE 6 North America Carcinoembryonic Antigen Market, by Country, 2015-2027 (US$ Mn)

TABLE 7 Europe Carcinoembryonic Antigen Market, by Source, 2015-2027 (US$ Mn)

TABLE 8 Europe Carcinoembryonic Antigen Market, by Country/Region, 2015-2027 (US$ Mn)

TABLE 9 Asia Pacific Carcinoembryonic Antigen Market, by Source, 2015-2027 (US$ Mn)

TABLE 10 Asia Pacific Carcinoembryonic Antigen Market, by Country/Region, 2015-2027 (US$ Mn)

TABLE 11 Latin America Carcinoembryonic Antigen Market, by Source, 2015-2027 (US$ Mn)

TABLE 12 Latin America Carcinoembryonic Antigen Market, by Country/Region, 2015-2027 (US$ Mn)

TABLE 13 Middle East Carcinoembryonic Antigen Market, by Source, 2015-2027 (US$ Mn)

TABLE 14 Middle East Carcinoembryonic Antigen Market, by Country/Region, 2015-2027 (US$ Mn)

TABLE 15 Africa Carcinoembryonic Antigen Market, by Source, 2015-2027 (US$ Mn)

TABLE 16 Africa Carcinoembryonic Antigen Market, by Country/Region, 2015-2027 (US$ Mn)

TABLE 17 F. Hoffmann-La Roche Ltd : Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)

TABLE 18 Abbott Diagnostics: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)

TABLE 19  GenWay Biotech Inc.,: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)

TABLE 20 Quest Diagnostics,: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)

TABLE 21 Creative Diagnostics,: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)

TABLE 22  Correlogic Systems, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments

TABLE 23 , Omega Diagnostics Group PLC: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments

TABLE 24 RayBiotech, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments

TABLE 25 Boster Biological Technology : Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments

Qiagen N.V.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments

Frequently Asked Questions

Which are the different types of carcinoembryonic antigen by application?

Carcinoembryonic Antigen offer wide application areas such as Colorectal cancer, Pancreatic cancer, Ovarian cancer, Breast cancer, Thyroid cancer and Others. Among all the applications, Colorectal cancer segment accounts for the largest market share and continue its dominance in the forecast period.

Who are the key players in the global industry?

Some of the leading players operating in carcinoembryonic antigen industry include, F. Hoffmann-La Roche Ltd, Abbott Diagnostics, GenWay Biotech Inc., Quest Diagnostics, Creative Diagnostics, Correlogic Systems, Inc., Omega Diagnostics Group PLC and RayBiotech, Inc. The prominent players in the market focusing on technological innovation and research & development which is expected to boosts the market growth.

Which is the fastest growing End user segment for global industry?

The end user industry of carcinoembryonic antigen are hospitals, laboratories and others. Among end user industries, hospitals segment accounts for the major market share in 2020.

Which is the leading regional market for global industry?

North America hold the major revenue share owing to rise in number of cancer patients and rapidly growing healthcare infrastructure.

What will be the CAGR (2021 – 2027) of in global industry?

The market is anticipated to grow at a CAGR of 4.1% throughout the forecast period, in terms of revenue

OTC Vitamins Dietary Supplements Market

Published:
Report ID: 35994

US Retail Pharmacy Market

Published:
Report ID: 32801

Liposomes Market

Published:
Report ID: 35888

UK Iron Supplement Market

Published:
Report ID: 35709

U.S. Iron Supplement Market

Published:
Report ID: 35688

Malignant Ascites Market

Published:
Report ID: 11184

Middle East and Africa In-Vitro Fertilization (IVF) Market

Published:
Report ID: 35578

Chronic Myeloid Leukemia (CML) Treatment Market

Published:
Report ID: 2939

Combination Therapies In Aesthetics Market

Published:
Report ID: 35434

CAR T-Cell Therapy Market

Published:
Report ID: 2051

OTC Cough Cold And Allergy Medicine Market

Published:
Report ID: 20062

Heart Health Supplements Market

Published:
Report ID: 6184

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN